191 related articles for article (PubMed ID: 31247718)
1. Dendrimer-Based Platform for Effective Capture of Tumor Cells after TGFβ
Myung JH; Cha A; Tam KA; Poellmann M; Borgeat A; Sharifi R; Molokie RE; Votta-Velis G; Hong S
Anal Chem; 2019 Jul; 91(13):8374-8382. PubMed ID: 31247718
[TBL] [Abstract][Full Text] [Related]
2. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
4. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
5. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
7. Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application.
Bu J; Nair A; Kubiatowicz LJ; Poellmann MJ; Jeong WJ; Reyes-Martinez M; Armstrong AJ; George DJ; Wang AZ; Zhang T; Hong S
Biosens Bioelectron; 2020 Aug; 162():112250. PubMed ID: 32392161
[TBL] [Abstract][Full Text] [Related]
8. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
[TBL] [Abstract][Full Text] [Related]
10. Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.
Myung JH; Eblan MJ; Caster JM; Park SJ; Poellmann MJ; Wang K; Tam KA; Miller SM; Shen C; Chen RC; Zhang T; Tepper JE; Chera BS; Wang AZ; Hong S
Clin Cancer Res; 2018 Jun; 24(11):2539-2547. PubMed ID: 29545463
[No Abstract] [Full Text] [Related]
11. Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance.
Zhou J; Zhu X; Wu S; Guo J; Zhang K; Xu C; Chen H; Jin Y; Sun Y; Zheng S; Chen Y
Cancer Biol Med; 2020 Feb; 17(1):169-180. PubMed ID: 32296584
[No Abstract] [Full Text] [Related]
12. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
13. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
14. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
15. EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis.
Kitz J; Goodale D; Postenka C; Lowes LE; Allan AL
Clin Exp Metastasis; 2021 Feb; 38(1):97-108. PubMed ID: 33415568
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Wang G; Benasutti H; Jones JF; Shi G; Benchimol M; Pingle S; Kesari S; Yeh Y; Hsieh LE; Liu YT; Elias A; Simberg D
Colloids Surf B Biointerfaces; 2018 Jan; 161():200-209. PubMed ID: 29080504
[TBL] [Abstract][Full Text] [Related]
17. Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Togo S; Shimizu H; Saito M
J Transl Med; 2018 Oct; 16(1):287. PubMed ID: 30342534
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
[TBL] [Abstract][Full Text] [Related]
19. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]